CPS1
CPS1 (carbamoyl-phosphate synthase 1, also known as GATD6) is a mitochondrial enzyme that catalyses the first committed step of the urea cycle. It has a central role in removing excess ammonia from the cell. Browse Assay Genie's current range of CPS1 research reagents below, or read on for the biology behind the target.
CPS1 catalyses the synthesis of carbamoyl phosphate from ammonia and bicarbonate. This reaction is the first committed step of the urea cycle, the pathway in ureotelic animals that removes excess ammonia and urea from the cell. Because it commits ammonia to the cycle, the enzyme is a key point of nitrogen handling in the mitochondrion. UniProt names the protein carbamoyl-phosphate synthase [ammonia], mitochondrial, which distinguishes it from other carbamoyl-phosphate synthetases.
The CPS1 gene encodes a mitochondrial protein classed by HGNC within the carbamoyl-phosphate synthetases, the glutamine amidotransferase class 1 domain containing group and the ATP-grasp fold containing group. UniProt lists subcellular locations in the mitochondrion, the nucleolus and the cell membrane. The encoded protein may also represent a core mitochondrial nucleoid protein. Three transcript variants encoding different isoforms have been described, and the shortest isoform may not be localised to the mitochondrion. Orthologous genes are named Cps1 in both mouse and rat, which allows the CPS1 protein to be studied in rodent models.
Mutations in the CPS1 gene have been associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation. Earlier names for the gene include carbamoyl-phosphate synthetase 1, mitochondrial, and the alias GATD6 also appears in the literature. Researchers use CPS1 antibody and CPS1 ELISA kit reagents to study ammonia detoxification, mitochondrial metabolism and these disease associations.
CPS1 catalyses the first committed step of the urea cycle, making it a central subject in studies of ammonia removal.
Mutations in CPS1 are associated with carbamoyl phosphate synthetase deficiency, so the enzyme is studied in urea cycle disorders.
The encoded protein may represent a core mitochondrial nucleoid protein, prompting work on its roles beyond nitrogen metabolism.
CPS1 variants are linked to susceptibility to persistent pulmonary hypertension and to venoocclusive disease after bone marrow transplantation.
CPS1 is a mitochondrial enzyme that synthesises carbamoyl phosphate from ammonia and bicarbonate. This is the first committed step of the urea cycle, which removes excess ammonia from the cell. The reaction is classed under EC 6.3.4.16.
The gene is also called GATD6, and earlier names include carbamoyl-phosphate synthetase 1, mitochondrial. Three transcript variants encode different isoforms. The shortest isoform may not be localised to the mitochondrion, so check the datasheet of any product for its validated reactivity.
Mutations in CPS1 are associated with carbamoyl phosphate synthetase deficiency, susceptibility to persistent pulmonary hypertension, and susceptibility to venoocclusive disease after bone marrow transplantation. Mouse and rat both carry an ortholog named Cps1.
Other targets with similar gene symbols and metabolic enzymes with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P31327; product specifications from Assay Genie datasheets.